Skip to content

Clinical randomized controlled study of probiotic food (Zolecon) improving chronic constipation in middle-aged and elderly patients

Clinical randomized controlled study of probiotic food (Zolecon) improving chronic constipation in middle-aged and elderly patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101101
Enrollment
Unknown
Registered
2025-04-21
Start date
2025-04-21
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Constipation

Interventions

Sponsors

The Second People's Hospital of Jingdezhen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to No maximum

Inclusion criteria

Inclusion criteria: > = 45 years old who meet the criteria for chronic constipation in middle-aged and elderly people, with normal weight and height. Diagnostic criteria for chronic constipation in middle-aged and elderly people: 1. The following > = 2 items must be included. (1) At least 25% of the time, bowel movements are laborious; (2) At least 25% of the time the bowel movements are lumpy or hard; (3) at least 25% of the time, there is a feeling of incomplete bowel movements; (4) At least 25% of the time, there is anorectal obstruction or blockage; (5) At least 25% of the time defecation requires manual assistance (such as finger defecation assistance, pelvic floor support); (6) Spontaneous bowel movements less than 3 times a week. 2. Loose stools rarely occur when laxatives are not used. 3. Symptoms that do not meet the diagnostic criteria for irritable bowel syndrome with constipation (IBS-C) have appeared for at least 6 months before diagnosis, and the symptoms meet the above diagnostic criteria in the past 3 months.

Exclusion criteria

Exclusion criteria: 1. Subjects with previous or current intestinal obstruction, tumors, ulcers, and other diseases that may lead to secondary constipation of the digestive tract. 2. Subjects with a prior history of gastrointestinal surgery. 3. Subjects with major diseases, such as severe cardiovascular, liver, and kidney diseases. 4. Subjects who are allergic to probiotics. 5. Subjects who have taken antibiotics, probiotics, and other drugs that affect the efficacy evaluation within three weeks before enrollment.

Design outcomes

Primary

MeasureTime frame
5-HT;Composition of gut microbiota;

Countries

China

Contacts

Public ContactJiangqing Yu

Jingdezhen Second People's Hospital

yujiangqing1976@163.com+86 137 6781 4995

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026